Searchable abstracts of presentations at key conferences in endocrinology

ea0069p29 | Poster Presentations | SFENCC2020

Calcium sensing receptor mutation causing familial hypocalciuric hypercalcaemia

Galloway Natasha

Case history: A 16 month old boy was referred to Community Paediatrics with developmental delay. Bloods taken as part of a developmental delay screen, revealed a raised calcium, with an inappropriately normal parathyroid hormone (PTH) and a normal vitamin D. There was no family history of hypercalcaemia. Blood tests in the boy’s mother and grandmother also showed hypercalcaemia.Investigations: Calcium was raised at 3.46 mmol/l. A urinary calcium cre...

ea0062p18 | Poster Presentations | EU2019

A rare cause of hypercalcemia and nephrolithiasis

Andrabi Syed Basharat , Kurera Isuri , Maltese Guisseppe , Snape Katie , Bano Gul

We present a 67 years old male originally from Cyprus who presented with Hypercalcemia. He had renal calculi twice and required Laparoscopic procedure. In his family history his 3 siblings had confirmed raised calcium and PTH and 2 other siblings had renal calculi. One of his brother, had surgery for primary hyperparathyroidism twice but no parathyroid adenoma was found and his calcium remained high. Patients’ calcium was 2.81 mmol/l (2.15–2.50), 25 HVD 82 nmol/l (75...

ea0063p682 | Pituitary and Neuroendocrinology 2 | ECE2019

Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study

Roumeau Sylvain , Thevenon Joannice , Ouchchane Lemlih , Maqdasy Salwan , Batisse-Lignier Marie , Duale Christian , Tauveron Igor , Devoize Laurent

Objective: Maxillofacial manifestations of acromegaly are well described (prognathism, inter-dental space enlargement, occlusion disorder, macroglossia, prominent cheekbones…) [1] but the dental and periodondal impact of this disease has been poorly investigated. The scientific literature on this topic is scarce, with controversies about gingival and cement enlargement. Our goal is to describe the oro-dental state of these patients as precisely as possible and to study t...

ea0049s12.2 | New development in Graves' Orbitopathy | ECE2017

Management of Graves orbitopathy

Bartalena Luigi

Management of Graves’ orbitopathy (GO) depends on the severity and activity of the disease. Guidelines for the management of GO have recently been published by EUGOGO (European Group on Graves’ Orbitopathy) (European Thyroid Journal 2016 5 9–26). Assessment of GO by standardized criteria is fundamental to determine the type of intervention. General measures for all patients with GO, irrespective of the degree of severity and activity, i...

ea0044s2.2 | Grappling with the future of anti-inflammatory steroids | SFEBES2016

Combination therapies that lighten the glucocorticoid load

Newton Robert

We ask that you provide an abstract of your lecture by using the online submission system. Please click here to create an account and, when asked, please submit your abstract under the INVITED SPEAKER category. Abstracts should be submitted in order for it to be included in the Journal Endocrine Abstracts. Any talks which do not have an abstract submitted will appear in Endocrine Abstracts with the phrase “abstract unavailable”. Abstracts should be no longer...

ea0044s4.3 | Advances in the genetic understanding of endocrine disease | SFEBES2016

Somatic mutations and adrenal remodelling in hyperaldosteronism

Brown Morris

Primary Aldosteronism (PA), due to a unilateral aldosterone-producing adenoma of the adrenal (APA), is the commonest curable cause of Hypertension, but the prospects for cure fall with age. APAs rarely increase in size, suggesting an origin much earlier than the development of resistant hypertension. Most APAs have gain-of-function somatic mutations which result in increased Ca2+ entry, and constitutive activation of aldosterone production. Women with larger APAs, a...

ea0038s2.1 | Zoning in on adrenal tumours | SFEBES2015

Somatic mutations and adrenal remodelling in hyperaldosteronism

Brown Morris

Primary Aldosteronism (PA), due to a unilateral aldosterone-producing adenoma of the adrenal (APA), is the commonest curable cause of Hypertension, but the prospects for cure fall with age. APAs rarely increase in size, suggesting an origin much earlier than the development of resistant hypertension. Most APAs have gain-of-function somatic mutations which result in increased Ca2+ entry, and constitutive activation of aldosterone production. Women with larger APAs, a...

ea0036P26 | (1) | BSPED2014

Can proportion of children achieving HbA1c below 58 mmol/mol within the first year of diagnosis be used as a standard of quality of care provided for children with type 1 diabetes?

Harrison Clare , Wilkinson Ingrid , Anand Binu , Furley Rachel , Abdullah Nadeem , Bhandari Jasjit , Puthi Vijith , Rafiq Anjum , Lim Sharon , Manoharan Karthikeyini , Gomez Alina , Harham Bharat , Bude Lija , Datta Vipan

Background: Children with HbA1cs in target within the first year of diagnosis of diabetes show tracking of future results1 and experience fewer long term complications.2 This phenomenon is called ‘metabolic memory.3 HbA1C depends on a combination of patient factors and quality of care offered by the team (intensive insulin, communication, and support). We hypothesized that well managed, supported, patients should achieve target HbA1cs at l...

ea0035p698 | Male reproduction | ECE2014

Waist circumference and waist-to-height ratio in relation to semen quality and serum reproductive hormones levels among Estonian fertile men

Ehala-Aleksejev Kristel , Punab Margus

Introduction: It has been suggested that BMI, especially above 30, is associated with subfertility in men. At the same time validity of BMI to distinguish variability in body composition, have been questioned (MacDonald, 2010). In our study, we employed more accurate surrogate measures of adiposity to investigate the relations of semen parameters and reproductive hormones with waist circumference (WC) and waist-to-height ratio (WHtR).Methods: During 2010...

ea0070aep362 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Cardiovascular manifestation of alkaptonuria

Shah Preet , Hingolikar Ankita

Case History: A 64-year-old gentleman presented with progressive exertional breathlessness since 1 year. He had started noticing pigmentation in the eyes 2 years back, and gave a history of passing black coloured urine since childhood. He had never consulted a medical professional for the same. Examination revealed hyperpigmentation of both ears and conjunctivae, and an ejection systolic murmur (Grade V) at the aortic area, which radiated to both his carotids. A sample of his ...